The federal Project Grant award, valued at $1,224,997.00, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to fund research at Cold Spring Harbor Laboratory (CSHL) to enhance immunity in colorectal cancer liver metastases. CSHL, a renowned non-profit research institution, will conduct innovative scientific studies to advance fundamental understanding and develop potential medical applications in this area over the award's 4-year performance period from Aug 1, 2024 to Jul 31, 2028. The laboratory's deep expertise in cancer biology, genomics, and immunology makes it well-equipped to deliver cutting-edge research that aims to improve health outcomes for military service members, veterans, and the broader public.
Generated 3/4/25, 4:54 AM